The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The specific sizes that determine optimal nanoparticle tumor accumulation, penetration, and treatment remain inconclusive because many studies compared nanoparticles with multiple physicochemical variables (e.g., chemical structures, shapes, and other physical properties) in addition to the size. In this study, we synthesized amphiphilic block copolymers of 7-ethyl-10-hydroxylcamptothecin (SN38) prodrug and fabricated micelles with sizes ranging from 20 to 300 nm from a single copolymer. The as-prepared micelles had exactly the same chemical structures and similar physical properties except for size, which provided an ideal platform for a systematic investigation of the size effects in cancer drug delivery. We found that the micelle's blood circulation time and tumor accumulation increased with the increase in their diameters, with optimal diameter range of 100 to 160 nm. However, the much higher tumor accumulation of the large micelles (100 nm) did not result in significantly improved therapeutic efficacy, because the large micelles had poorer tumor penetration than the small ones (30 nm). An optimal size that balances drug accumulation and penetration in tumors is critical for improving the therapeutic efficacy of nanoparticulate drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As reported, micelle with small sizes (e.g., 30 nm) has demonstrated more efficient penetration in tumor and higher anticancer activity of the drug [75].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [75]
In the citing paper
“The role of the size of nanocarriers in their biodistribution is verywell described in the literature [53,54] and has been more recently confirmed also in the case of polymeric micelles [55,56].”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [55]
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Cited by
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Self-citationBlock copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Self-citationEnzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
Zhou, Q., Shao, S., Wang, J., Xu, C., Xiang, J., Piao, Y., Zhou, Z., Yu, Q., Tang, J., Liu, X., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0485-z · Cited by 819
Self-citationStimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Self-citationLi, H.-J., Du, J.-Z., Liu, J., Du, X.-J., Shen, S., Zhu, Y.-H., Wang, X., Ye, X., Nie, S., & Wang, J. (2016) · ACS Nano · doi:10.1021/acsnano.6b02326 · Cited by 537
Self-citationBiodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Ren, Z., Sun, S., Sun, R., Cui, G., Hong, L., Rao, B., Li, A., Yu, Z., Kan, Q., & Mao, Z. (2020) · Advanced Materials · doi:10.1002/adma.201906024 · Cited by 446
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Feng, L., Dong, Z., Tao, D., Zhang, Y., & Liu, Z. (2018) · National Science Review · doi:10.1093/nsr/nwx062 · Cited by 426
Engineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Self-citationMultifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics
Zhao, S., Yu, X., Qian, Y., Chen, W., & Shen, J. (2020) · Theranostics · doi:10.7150/thno.42564 · Cited by 390
Nanoparticle Size Effects in Biomedical Applications
Dolai, J., Mandal, K., & Jana, N. R. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00987 · Cited by 358
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 379
Self-citationCheng, Y.-H., He, C., Riviere, J. E., Monteiro-Riviere, N. A., & Lin, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b08142 · Cited by 362
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 342
Ye, M., Han, Y., Tang, J., Piao, Y., Liu, X., Zhou, Z., Gao, J., Rao, J., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201702342 · Cited by 338
Self-citationChen, S., Zhong, Y., Fan, W., Xiang, J., Wang, G., Zhou, Q., Wang, J., Geng, Y., Sun, R., Zhang, Z., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00701-4 · Cited by 325
Self-citationInfluencing factors and strategies of enhancing nanoparticles into tumors in vivo
Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 274
Strategies to improve tumor penetration of nanomedicines through nanoparticle design
Zhang, Y., Lin, R., Li, H., He, W., Du, J., & Wang, J. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1519 · Cited by 268
Self-citationLi, J., Li, Y., Wang, Y., Ke, W., Chen, W., Wang, W., & Ge, Z. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03531 · Cited by 263
Ji, C., Gao, Q., Dong, X., Yin, W., Gu, Z., Gan, Z., Zhao, Y., & Yin, M. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807602 · Cited by 258
Li, Y., Liu, G., Ma, J., Lin, J., Lin, H., Su, G., Chen, D., Ye, S., Chen, X., Zhu, X., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.011 · Cited by 255
Wu, W., Luo, L., Wang, Y., Wu, Q., Dai, H.-B., Li, J.-S., Durkan, C., Wang, N., & Wang, G.-X. (2018) · Theranostics · doi:10.7150/thno.23459 · Cited by 246
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
Advanced functional polymer materials
Wang, K., Amin, K., An, Z., Cai, Z., Chen, H., Chen, H., Dong, Y., Feng, X., Fu, W., Gu, J., et al. (2020) · Materials Chemistry Frontiers · doi:10.1039/d0qm00025f · Cited by 239
Self-citationpH-sensitive biomaterials for drug delivery
Zhuo, S., Zhang, F., Yu, J., Zhang, X., Yang, G., & Liu, X. (2020) · Molecules · doi:10.3390/molecules25235649 · Cited by 247
Lv, Y., Xu, C., Zhao, X., Lin, C., Yang, X., Xin, X., Zhang, L., Qin, C., Han, X., Yang, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b08051 · Cited by 235
Wang, Z., Ju, Y., Ali, Z., Yin, H., Sheng, F., Lin, J., Wang, B., & Hou, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-12142-4 · Cited by 232
Dong, X., Liu, H.-J., Feng, H.-Y., Yang, S.-C., Liu, X.-L., Lai, X., Lu, Q., Lovell, J. F., Chen, H.-Z., & Fang, C. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04236 · Cited by 223
The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency
Liang, Q., Bie, N., Yong, T., Tang, K., Shi, X., Wei, Z., Jia, H., Zhang, X., Zhao, H., Huang, W., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0405-4 · Cited by 216
Tumor microenvironment responsive drug delivery systems
He, Q., Chen, J., Yan, J., Cai, S., Xiong, H., Liu, Y., Peng, D., Mo, M., & Liu, Z. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.08.003 · Cited by 219
Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration
Li, Z., Shan, X., Chen, Z., Gao, N., Zeng, W., Zeng, X., & Mei, L. (2021) · Advanced Science · doi:10.1002/advs.202002589 · Cited by 218
Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake
Jin, Q., Deng, Y., Chen, X., & Ji, J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07746 · Cited by 219
Zhou, Q., Dong, C., Fan, W., Jiang, H., Xiang, J., Qiu, N., Piao, Y., Xie, T., Luo, Y., Li, Z., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119902 · Cited by 218
Self-citationYin, W., Ke, W., Chen, W., Xi, L., Zhou, Q., Mukerabigwi, J. F., & Ge, Z. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.032 · Cited by 202
Zhang, P., Wang, J., Chen, H., Zhao, L., Chen, B., Chu, C., Liu, H., Qin, Z., Liu, J., Tan, Y., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b09396 · Cited by 200
Self-citationEnhancing tumor penetration of nanomedicines
Sun, Q., Ojha, T., Kiessling, F., Lammers, T., & Shi, Y. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00068 · Cited by 198
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 188
Self-citationWang, Y., Luo, S., Wu, Y., Tang, P., Liu, J., Liu, Z., Shen, S., Ren, H., & Wu, D. (2020) · ACS Nano · doi:10.1021/acsnano.0c06415 · Cited by 195
Biomedical polymers: synthesis, properties, and applications
Chen, W.-H., Chen, Q.-W., Chen, Q., Cui, C., Duan, S., Kang, Y., Liu, Y., Liu, Y., Muhammad, W., Shao, S., et al. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1243-5 · Cited by 187
Self-citationImpact of Semiconducting Perylene Diimide Nanoparticle Size on Lymph Node Mapping and Cancer Imaging
Yang, Z., Tian, R., Wu, J., Fan, Q., Yung, B. C., Niu, G., Jacobson, O., Wang, Z., Liu, G., Yu, G., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b01261 · Cited by 193
Dai, L., Li, K., Li, M., Zhao, X., Luo, Z., Lu, L., Luo, Y., & Cai, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707249 · Cited by 193
Li, N., Cai, H., Jiang, L., Hu, J., Bains, A., Hu, J., Gong, Q., Luo, K., & Gu, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b15505 · Cited by 188
Liu, Q., Zhao, K., Wang, C., Zhang, Z., Zheng, C., Zhao, Y., Zheng, Y., Liu, C., An, Y., Shi, L., et al. (2019) · Advanced Science · doi:10.1002/advs.201801423 · Cited by 190
Chen, Q., Chen, J., Liang, C., Feng, L., Dong, Z., Song, X., Song, G., & Liu, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.006 · Cited by 188
Nanoplatform-based cascade engineering for cancer therapy
Chen, J., Zhu, Y., Wu, C., & Shi, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00607f · Cited by 182
Sun, Y., & Davis, E. (2021) · Nanomaterials · doi:10.3390/nano11030746 · Cited by 165
Microfluidic Methods for Fabrication and Engineering of Nanoparticle Drug Delivery Systems
Zhang, L., Chen, Q., Ma, Y., & Sun, J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00853 · Cited by 174
Ridolfo, R., Tavakoli, S., Junnuthula, V., Williams, D. S., Urtti, A., & van Hest, J. C. M. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.0c00726 · Cited by 166
Luo, C., Sun, J., Sun, B., Liu, D., Miao, L., Goodwin, T. J., Huang, L., & He, Z. (2016) · Small · doi:10.1002/smll.201601597 · Cited by 174
Ou, H., Cheng, T., Zhang, Y., Liu, J., Ding, Y., Zhen, J., Shen, W., Xu, Y., Yang, W., Niu, P., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.034 · Cited by 169
Zhang, Z., Wang, H., Tan, T., Li, J., Wang, Z., & Li, Y. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801840 · Cited by 165
Facile Generation of Tumor‐pH‐Labile Linkage‐Bridged Block Copolymers for Chemotherapeutic Delivery
Sun, C., Liu, Y., Du, J., Cao, Z., Xu, C., & Wang, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509507 · Cited by 165
Self-citationYang, G., Sun, X., Liu, J., Feng, L., & Liu, Z. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600722 · Cited by 162
Mandal, A., Gote, V., Pal, D., Ogundele, A., & Mitra, A. K. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2556-5 · Cited by 169
Stimuli-Responsive “Cluster Bomb” for Programmed Tumor Therapy
Lei, Q., Wang, S.-B., Hu, J.-J., Lin, Y.-X., Zhu, C.-H., Rong, L., & Zhang, X.-Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b03088 · Cited by 160
He, X., Yang, Y., Han, Y., Cao, C., Zhang, Z., Li, L., Xiao, C., Guo, H., Wang, L., Han, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209260120 · Cited by 165
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 160
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Liang, J., Wang, H., Ding, W., Huang, J., Zhou, X., Wang, H., Dong, X., Li, G., Chen, E., Zhou, F., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc3646 · Cited by 159
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156
“, 30 nm) has demonstrated more efficient penetration in tumor and higher anticancer activity of the drug [75].”
BackgroundThe in vivo fate of polymeric micelles
Cai, Y., Qi, J., Lu, Y., He, H., & Wu, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114463 · Cited by 154
Zhang, Y., Huang, F., Ren, C., Liu, J., Yang, L., Chen, S., Chang, J., Yang, C., Wang, W., Zhang, C., et al. (2019) · Advanced Science · doi:10.1002/advs.201801806 · Cited by 152
Niu, Y., Zhu, J., Li, Y., Shi, H., Gong, Y., Li, R., Huo, Q., Ma, T., & Liu, Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.012 · Cited by 154
Liposomal Texaphyrin Theranostics for Metastatic Liver Cancer
Lee, M. H., Kim, E. J., Lee, H., Kim, H. M., Chang, M. J., Park, S. Y., Hong, K. S., Kim, J. S., & Sessler, J. L. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09713 · Cited by 149
Safety Evaluation of Nanotechnology Products
Domb, A. J., Sharifzadeh, G., Nahum, V., & Hosseinkhani, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101615 · Cited by 151
Chen, B., Dai, W., Mei, D., Liu, T., Li, S., He, B., He, B., Yuan, L., Zhang, H., Wang, X., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.014 · Cited by 142
Zhao, T., Wang, P., Li, Q., Al-Khalaf, A. A., Hozzein, W. N., Zhang, F., Li, X., & Zhao, D. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711354 · Cited by 144
Recent advances in drug delivery systems for enhancing drug penetration into tumors
He, B., Sui, X., Yu, B., Wang, S., Shen, Y., & Cong, H. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1831106 · Cited by 146
Self-citationBao, Y., Yin, M., Hu, X., Zhuang, X., Sun, Y., Guo, Y., Tan, S., & Zhang, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.003 · Cited by 139
Molecular engineering solutions for therapeutic peptide delivery
Acar, H., Ting, J., Srivastava, S., LaBelle, J. L., & Tirrell, M. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00536a · Cited by 145
Nanoparticulation of Prodrug into Medicines for Cancer Therapy
Zhang, Y., Cui, H., Zhang, R., Zhang, H., & Huang, W. (2021) · Advanced Science · doi:10.1002/advs.202101454 · Cited by 135
Self-citationRabanel, J., Adibnia, V., Tehrani, S. F., Sanche, S., Hildgen, P., Banquy, X., & Ramassamy, C. (2018) · Nanoscale · doi:10.1039/c8nr04916e · Cited by 137
Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer
Liu, Y., Xu, C., Iqbal, S., Yang, X., & Wang, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.004 · Cited by 135
Self-citationBi, H., Dai, Y., Yang, P., Xu, J., Yang, D., Gai, S., He, F., Liu, B., Zhong, C., An, G., et al. (2018) · Small · doi:10.1002/smll.201703809 · Cited by 129
Transcytosis of Nanomedicine for Tumor Penetration
Liu, Y., Huo, Y., Yao, L., Xu, Y., Meng, F., Li, H., Sun, K., Zhou, G., Kohane, D. S., & Tao, K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03211 · Cited by 129
Smart transformable nanoparticles for enhanced tumor theranostics
Chen, J., Jiang, Z., Zhang, Y. S., Ding, J., & Chen, X. (2021) · Applied Physics Reviews · doi:10.1063/5.0061530 · Cited by 127
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 155
Mou, Q., Ma, Y., Zhu, X., & Yan, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.037 · Cited by 127
Microfluidic Isolation and Enrichment of Nanoparticles
Xie, Y., Rufo, J., Zhong, R., Rich, J. T., Li, P., Leong, K. W., & Huang, T. J. (2020) · ACS Nano · doi:10.1021/acsnano.0c06336 · Cited by 123
Shu, M., Tang, J., Chen, L., Zeng, Q., Li, C., Xiao, S., Jiang, Z., & Liu, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120574 · Cited by 119
Self-citationYu, Q., Qiu, Y., Li, J., Tang, X., Wang, X., Cun, X., Xu, S., Liu, Y., Li, M., Zhang, Z., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.040 · Cited by 120
Jia, H., Zhu, Y., Liu, X., Pan, G., Gao, G., Sun, W., Zhang, X., Jiang, Y., & Wu, F. (2019) · ACS Nano · doi:10.1021/acsnano.9b05749 · Cited by 118
Self-citationSun, X. J., Zhang, G., Du, R., Xu, R. F., Zhu, D., Qian, J., Bai, G., Yang, C., Zhang, Z., Zhang, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.004 · Cited by 114
Programmed Nanoparticle‐Loaded Nanoparticles for Deep‐Penetrating 3D Cancer Therapy
Kim, J., Jo, C., Lim, W., Jung, S., Lee, Y. M., Lim, J., Lee, H., Lee, J., & Kim, W. J. (2018) · Advanced Materials · doi:10.1002/adma.201707557 · Cited by 113
Hou, X., Zhong, D., Chen, H., Gu, Z., Gong, Q., Ma, X., Zhang, H., Zhu, H., & Luo, K. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119662 · Cited by 116
Zeng, W., Wu, X., Chen, T., Sun, S., Shi, Z., Liu, J., Ji, X., Zeng, X., Guan, J., Mei, L., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008362 · Cited by 114
Smart transformable nanomedicines for cancer therapy
Wang, Y., Li, S., Wang, X., Chen, Q., He, Z., Luo, C., & Sun, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120737 · Cited by 112
Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue
Munir, M. U. (2022) · Cancers · doi:10.3390/cancers14122904 · Cited by 116
Su, Y., Yu, T.-W., Chiang, W., Chiu, H., Chang, C., Chiang, C., & Hu, S. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700056 · Cited by 110
Wang, Y., Wang, Z., Xu, C., Tian, H., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.025 · Cited by 110
Xu, M., Zhang, C. Y., Wu, J., Zhou, H., Bai, R., Shen, Z., Deng, F., Liu, Y., & Liu, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b13059 · Cited by 110
Extracellular vesicles for tumor targeting delivery based on five features principle
Yong, T., Wang, D., Li, X., Yan, Y., Hu, J., Gan, L., & Yang, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.039 · Cited by 108
Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
Xu, C., Zhang, H., Sun, C., Liu, Y., Shen, S., Yang, X., Zhu, Y., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.031 · Cited by 106
Self-citationTumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment
Yang, Y. P., Wu, H., Liu, B., & Liu, Z. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114004 · Cited by 107
Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery
Wang, X., Zhang, H., Chen, X., Wu, C., Ding, K., Sun, G., Luo, Y., & Xiang, D. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.043 · Cited by 108
Duan, D., Liu, H., Xu, M., Chen, M., Han, Y., Shi, Y., & Liu, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17660 · Cited by 105
Chen, L., Zhao, T., Zhao, M., Wang, W., Sun, C., Liu, L., Li, Q., Zhang, F., Zhao, D., & Li, X. (2020) · Chemical Science · doi:10.1039/c9sc06260b · Cited by 105
Metadata
- Authors
- Wang, J., Mao, W., Lock, L. L., Tang, J., Sui, M., Sun, W., Cui, H., Xu, D., & Shen, Y.
- Affiliations
- State Key Laboratory of Chemical Engineering (CN)
- Johns Hopkins University (US)
- Zhejiang University (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Corresponding author
- Tang, Jianbin
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-07-15
- Volume
- 9
- Issue
- 7
- Pages
- 7195-7206
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2409322723
- Cited by
- 635
- References
- 35
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 36 · 2023: 59 · 2022: 70 · 2021: 75 · 2020: 83 · 2019: 89 · 2018: 76 · 2017: 58 · 2016: 37 · 2015: 3
- FWCI
- 21.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (21174128, 21274125, 51390481)
- Ministry of Education of the People's Republic of China (20110101130007)
- Ministry of Science and Technology of the People's Republic of China (2014CB931900)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- micelle size, tumor accumulation, tumor penetration, nanoparticle drug delivery, amphiphilic block copolymers, camptothecin, micelles, blood circulation time, treatment efficacy
- MeSH terms
- Irinotecan, Animals, Antineoplastic Agents, Phytogenic, Camptothecin, Female, Humans, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Inbred ICR, Mice, Nude, Micelles, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.